GSK Top Executive To Step Down at Year-End

GSK said Chief Executive Emma Walmsley would step down and be succeeded by commercial chief Luke Miels, as the drugmaker works to replenish its product lineup.

- BY ELENA VARDON AND ADRIÀ CALATAYUD

Walmsley will step down at the end of the year, having led the company through the Covid-19 pandemic, tensions with activist investor Elliott Management and a portfolio shakeup that included the spinoff of its consumer-healthcare business.